GleamWall
中文EN

PMI Picard Medical, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 2030617 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.6%
TTM net income YoY37.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin26.2%
Operating margin-267.2%
Net margin-371.2%
FCF margin—
EBITDA margin-264.0%

Returns

ROE-425.6%
ROA-175.2%
ROIC (approx.)-350.7%
Asset turnover0.47x

Leverage & solvency

Liabilities / assets85.3%
Debt / equity0.00x
Current ratio0.99x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.58x
Accruals ratio-73.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$217,000$2.95M$1.15M$1.01M$1.19M$2.13M$620,000$836,000
Cost of revenue$122,000$2.34M$875,000$598,000$1.32M$2.26M$978,000$700,000
Gross profit$95,000$616,000$275,000$411,000-$130,000-$127,000-$358,000$136,000
R&D expense$321,000$1.37M$1.90M$547,000$951,000$743,000$808,000$789,000
SG&A expense$1.88M$3.87M$2.89M$2.87M$2.41M$2.65M$2.08M$2.92M
Operating income-$2.10M-$4.63M-$4.51M-$3.00M-$3.49M-$3.52M-$3.25M-$3.57M
Interest expense—————$2.43M——
Pretax income-$2.22M-$5.65M-$7.62M-$4.29M-$10.43M-$6.72M-$5.53M-$8.85M
Income tax$0$7,000$0$4,000$0$0$31,000-$15,000
Net income-$2.22M-$5.66M-$7.62M-$4.29M-$10.43M-$6.72M-$5.56M-$8.84M
EBITDA-$2.06M-$4.58M-$4.46M-$2.96M-$3.45M-$3.08M-$3.20M-$3.53M
EPS (basic)-0.95-3.05-0.10—-9.57-42.39-0.80—
EPS (diluted)————————
Dividends declared per share————0.00———
Balance sheet
Cash & equivalents$67,000$38,000$121,000$7.45M$2.81M$410,000—$96,000
Receivables—————$1.30M—$513,000
Inventory$6.38M$5.97M$7.45M$7.30M$6.55M$7.00M—$8.12M
Current assets$7.63M$7.59M$9.51M$20.73M$11.59M$9.64M—$9.79M
PP&E, net$140,000$162,000$184,000$183,000$169,000$188,000—$227,000
Goodwill$615,000$615,000$615,000$615,000$615,000$615,000—$615,000
Intangibles$443,000$465,000$487,000$509,000$531,000$553,000—$596,000
Total assets$9.06M$9.17M$11.22M$22.55M$13.52M$11.70M—$12.11M
Current liabilities$7.73M$7.45M$12.66M$18.70M$5.37M$45.64M—$35.33M
Total liabilities$7.73M$7.45M$12.67M$18.76M$5.55M$45.93M—$35.84M
Shareholders' equity$1.33M$1.72M-$1.45M$3.79M$7.97M-$54.49M-$48.92M-$44.00M
Shares outstanding2.46M2.06M75.26M1.47M73.70M9.29M—7.94M
Cash flow statement
Operating cash flow-$2.00M-$1.35M-$3.80M-$4.38M-$6.51M-$2.54M-$2.24M-$3.15M
Capital expenditure$0$0$26,000—$0$0$0—
Free cash flow-$2.00M-$1.35M-$3.83M—-$6.51M-$2.54M-$2.24M—
Investing cash flow$0$0-$26,000—$0$0$0$0
Financing cash flow$2.03M$1.25M-$7.52M$13.02M$8.95M$2.28M$2.83M$3.23M
Depreciation & amortization$44,000$45,000$46,000$40,000$41,000$442,136$42,000$42,000
Stock-based compensation$93,000$1.38M$165,000$226,000$204,000$183,000$141,000$226,000

Free plan shows the latest 8 periods; Pro shows all 11 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.